Active ingredient validation

With the analysis of tissue microbiota in human cohorts or in vivo models, Vaiomer discovers next generation of probiotics. These new probiotics are a selection of bacterial taxa present with higher abundance in healthy patients compared to patients with metabolic disorders for example. Vaiomer tests their actions on different in vivo models as new active ingredients that modify the gut microbiota, tissue microbiota, and host metabolic pathways and physiology.

Vaiomer also validates existing prebiotics and probiotics and their beneficial impact on health, by studying their actions on the crosstalk between gut microbiota, tissue microbiota and host immune system/metabolism.


Taxonomic Profiling                                Host genes interaction network


Need more information ? You are welcome to contact our experts